Status
Conditions
Treatments
About
This protocol provides for the availability of spiramycin under compassionate-use conditions for the treatment of chronic diarrhea due to cryptosporidium in patients with a compromised immune system, thus deriving additional information regarding its safety and efficacy profile.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Exclusion Criteria
Co-existing Condition:
Patients with known sensitivity to macrolide antibiotics are excluded. Consideration must be given to the fact that spiramycin is a macrolide antibiotic and, therefore, may have the potential to induce hepatotoxicity.
Concurrent Medication:
Excluded:
Patients with known sensitivity to macrolide antibiotics are excluded. Consideration must be given to the fact that spiramycin is a macrolide antibiotic and, therefore, may have the potential to induce hepatotoxicity.
Prior Medication:
Excluded within 7 days of study entry:
Diagnosis of chronic diarrhea due to cryptosporidiosis and a compromised immune system but not limited to patients with AIDS.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal